Al Jernigan
Keller, TX (USA)
Role(s):
Other
Ideal Medical Technologies Inc.
Find More Startups
Startup
Location:
Asheville
Industry:
Healthcare
Year Founded:
2014
Number Employees:
1-10 people
Business Stage:
Growth (not profitable)
Entity Type:
Limited Liability Company
Description:
Ideal Medical Technologies is a highly innovative medical device company focused on the development and sale of an Artificial Pancreas system for use in both the ICU and general ward settings. IMT’s primary product, currently in the development stage, is FUSION, a new Artificial Pancreas system to be used to adjust, and improve glucose control for very sick, unstable, and recovering ICU & diabetic patients.
Ideal Medical Technologies (IMT) strategy initially is to fill a glaring need for an Artificial Pancreas system for use in the hospital setting, which can dramatically lower the cost of care and improve outcomes in all intensive care unit (ICU) patients and in diabetic patients admitted to a non-ICU setting. IMT has already completed proof of concept testing of its Artificial Intelligence based FUSION™ system (artificial pancreas) in animals and is now preparing to begin human trials with the eventual goal of obtaining FDA approval. The FDA has granted Breakthrough Medical Device status to IMT’s FUSION system, which should help to expedite regulatory approval. Given the current COVID-19 pandemic and the potential of the FUSION artificial pancreas system to lower the COVID-19 mortality rate by up to 30%, IMT plans to apply to the FDA for an Emergency Use Authorization (EUA) with the goal of bringing the FUSION system to market by Q4 2020.